Abstract
Fibromyalgia syndrome (FS) is characterized by widespread pain and tenderness at specific anatomic sites. Different theories have been proposed in the etiopathogenesis of this syndrome, and besides genetic, neuroendocrine, psychologic, and traumatic causes, infections have also been reported. The aim of the present study was to evaluate the presence of FS in patients with hepatitis C virus (HCV) infection. Ninety-five patients with chronic HCV infection and 95 healthy controls were enrolled in the study. The 1990 American College of Rheumatology classification criteria were used for the diagnosis of FS. Tender point count, pain intensity, sleep disturbance, stiffness, headache, paresthesia, fatigue, irritable bowel syndrome (IBS), and sicca- and Raynaud-like symptoms were assessed. Fibromyalgia was found in 18.9% of patients and 5.3% of healthy controls. Mean tender point count, pain intensity scored on a visual analog scale (VAS), sleep disturbance, stiffness, paresthesia, and fatigue were higher in the HCV group. No significant relationship was observed between the two groups regarding headache, IBS, and sicca- and Raynaud-like symptoms. In addition, mean tender point count and pain intensity scores were also significantly higher in HCV patients with FS than in control subjects with FS. All of the symptoms except stiffness were not statistically significant between the HCV and control groups with FS. Our results demonstrate a tendency toward higher prevalence of FS in patients with HCV infection. Besides various extrahepatic features, musculoskeletal disorders including fibromyalgia might be expected in the progression of HCV infection. Detailed examination of the patients helps to differentiate FS from other musculoskeletal complications of HCV infection. This will provide appropriate management approaches and better quality of life for them.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172
Bradley LA, Alarcon GS (1997) Fibromyalgia. Arthritis and allied conditions. A textbook of rheumatology. Williams and Wilkins, Baltimore, pp 1619–1640
Bennett RM (1993) Fibromyalgia and the facts. Sense or nonsense? Rheum Dis Clin North Am 19:45–59
Buchwald D, Goldenberg DL, Sullivan JL, Komaroff AL (1987) The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia. Arthritis Rheum 30:1132–1136
Buskila D, Gladman DD, Langevitz P, Urowitz S, Smythe HA (1990) Fibromyalgia in human immunodeficiency virus infection. J Rheumatol 17:1202–1206
Simms RW, Zerbini CA, Ferrante N, Anthony J, Felson DT, Craven DE (1992) Fibromyalgia syndrome in patients infected with human immunodeficiency virus. Am J Med 92: 368–3674
Nash P, Chard M, Hazleman B (1989) Chronic Coxsackie B infection mimicking primary fibromyalgia. J Rheumatol 16:1506–1508
Berg AM, Naides SJ, Simms RW (1993) Established fibromyalgia and parvovirus B19 infection. J Rheumatol 20:1941–1943
Leventhal LJ, Naides SJ, Freundlich B (1991) Fibromyalgia and parvovirus infection. Arthritis Rheum 34:1319–1324
Dinerman H, Steere AC (1992) Lyme disease associated with fibromyalgia. Ann Intern Med 117:281–285
Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E (1997) Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med 157:2497–2500
Rivera J, de Diego A, Trinchet M, Garcia Monforte A (1997) Fibromyalgia associated hepatitis C virus infection. Br J Rheumatol 36:981–985
Barkhuizen A, Rosen HR, Wolf S, Flora K, Benner K, Bennett RM (1999) Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol 94:1355–1360
Buskila D (2000) Hepatitis C-associated arthritis. Curr Opin Rheumatol 12:295–299
Willson RA (1997) Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 92:4–17
Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH (2001) Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 40:743–749
Gur A, Karakoc M, Nas K, Cevik R, Denli A, Sarac J (2002) Cytokines and depression in cases with fibromyalgia. J Rheumatol 29:358–361
Manning AP, Thompson WG, Eaton KW, Morris AF (1978) Towards positive diagnosis of irritable bowel. Br Med J 2:653–654
Demitrack MA (1998) Chronic fatigue syndrome and fibromyalgia. Dilemmas in diagnosis and clinical management. Psychiatr Clin North Am 21:671–692
van West D, Maes M (2001) Neuroendocrine and immune aspects of fibromyalgia. BioDrugs 15:521–531
Goulding C, O'Connell P, Murray FE (2001) Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol 13:507–511
Lubrano E, Iovino P, Tremolaterra F, Parsons WJ, Ciacci C, Mazzacca G (2001) Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder. Int J Colorectal Dis 16:211–215
Nelson DR (2001) The immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 5:931–953
Goldenberg DL (1993) Do infections trigger fibromyalgia? Arthritis Rheum 36:1489–1492
Winfield JB (1999) Pain in fibromyalgia. Rheum Dis Clin North Am 25:55–79
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kozanoglu, E., Canataroglu, A., Abayli, B. et al. Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatol Int 23, 248–251 (2003). https://doi.org/10.1007/s00296-003-0290-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-003-0290-7